Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (human)
DISEASE(S): Parkinson's Disease
SUBMITTER: Johannes Gloeckner
LAB HEAD: Christian Johannes Gloeckner
PROVIDER: PXD030063 | Pride | 2022-02-27
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
GUA3120-S02_13606_fraction1.raw | Raw | |||
GUA3120-S03_13606_fraction2.raw | Raw | |||
GUA3120-S06_14133_fraction1.raw | Raw | |||
GUA3120-S07_14133_fraction2.raw | Raw | |||
GUA3120-S08_14259_fraction1.raw | Raw |
Items per page: 5 1 - 5 of 26 |
Singh Ranjan K RK Soliman Ahmed A Guaitoli Giambattista G Störmer Eliza E von Zweydorf Felix F Dal Maso Thomas T Oun Asmaa A Van Rillaer Laura L Schmidt Sven H SH Chatterjee Deep D David Joshua A JA Pardon Els E Schwartz Thomas U TU Knapp Stefan S Kennedy Eileen J EJ Steyaert Jan J Herberg Friedrich W FW Kortholt Arjan A Gloeckner Christian Johannes CJ Versées Wim W
Proceedings of the National Academy of Sciences of the United States of America 20220301 9
Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) are a leading cause of the inherited form of Parkinson's disease (PD), while LRRK2 overactivation is also associated with the more common idiopathic form of PD. LRRK2 is a large multidomain protein, including a GTPase as well as a Ser/Thr protein kinase domain. Common, disease-causing mutations increase LRRK2 kinase activity, presenting LRRK2 as an attractive target for drug discovery. Currently, drug development has mainly fo ...[more]